Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study
Clinical trial NCT05900219 · UNKNOWN
Trial details
- NCT number
- NCT05900219
- Sponsor
- Shanghai Kechow Pharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-24
- Primary completion
- 2025-09-24
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.